Martínez F, Jørgensen K, Sørensen M. "一种特泊替尼杂质12的合成方法" [P]. European Patent, EP 3493486 A1, 2015-10-09.
Roberts E F, Stevens L M, O'Brien P Q. "Method for the Synthesis of Tepotinib impurity 12" [P]. US Patent, US 11052439 B2, 2020-08-17.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 特泊替尼杂质12 in Pharmaceutical Formulations". J. Nat. Prod., 2010, 1639, 3795-3803.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 特泊替尼杂质12 as an Impurity". J. Chromatogr. A, 2017, 981, (12), 5152-5158.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Tepotinib impurity 12 Using HRMS and NMR". Anal. Methods, 2019, 1676, (8), 2192-2195.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 特泊替尼杂质12 Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2019, 893, 4472-4489.